Ometa Labs

Ometa Labs operates at the intersection of AI/machine learning and drug delivery, offering a specialized software platform to decode untargeted metabolomics data. The company differentiates itself through a server-based, instrument-agnostic system built for collaboration, reproducibility, and custom workflow development, contrasting with legacy desktop solutions. It targets a broad market including pharmaceutical R&D, agricultural science, and environmental safety, with Corteva Agriscience cited as a user. Ometa's business model is focused on providing a software-as-a-service platform with extensive support and custom development options to research organizations.

A server-based, customizable software platform for untargeted metabolomics analysis. It uses AI/ML for high-throughput annotation and molecular networking of tandem mass spectrometry data, enabling visualization and discovery of unknown small molecules. The platform is instrument-agnostic, designed for collaboration, reproducibility, and secure deployment on-premise or in the cloud.

Ometa competes against desktop-based software from major mass spectrometry vendors (Thermo Fisher, Sciex, Waters, Bruker) and standalone bioinformatics tools. Its key differentiators are its server-based architecture for collaboration, instrument independence, and strong emphasis on custom development and support, contrasting with more rigid, off-the-shelf or academic-focused solutions.